English | Español
Patient Daily | Dec 3, 2025

ENT & Allergy Associates partners with Houston group for first Texas expansion
Patient Daily | Dec 3, 2025

American Lung Association opposes proposed weakening of federal vehicle fuel economy rules
Patient Daily | Dec 2, 2025

American Lung Association calls for widespread flu vaccination after severe 2024–25 season
Patient Daily | Dec 2, 2025

Experts question FDA official's claims linking child deaths to COVID-19 vaccines
Patient Daily | Dec 2, 2025

FDA drug center head Richard Pazdur announces retirement after brief tenure
Patient Daily | Dec 2, 2025

Roche announces promising interim results for new Alzheimer’s antibody trontinemab
Patient Daily | Dec 1, 2025

PhRMA Senior Director on 340B abuse: 'If Congress is serious about lowering drug costs, they must reform 340B'
Patient Daily | Dec 1, 2025

Six companies continue work on cell therapy despite recent industry exits

Trending
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor